Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Gagnon

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Lifetime Data Analysis|August 17, 2002
Modeling the effects of genetic factors on late-onset diseases in cohort studiesMark E Glickman, David R Gagnon
JAMA|November 10, 2020
New Statin Use and Mortality in Older Veterans-ReplyAriela R Orkaby, David R Gagnon, Luc Djousse
American Journal of Preventive Cardiology|September 9, 2024
Smoking and 10-year risk of cardiovascular and non-cardiovascular events after contemporary coronary stentingScott Kinlay, Melissa M Young, David R Gagnon
Journal of the American Geriatrics Society|March 26, 2021
Trends in 30-day mortality from COVID-19 among older adults in the Veterans Affairs systemBenjamin Seligman, Brian Charest, David R Gagnon, et al.
Journal of the American Heart Association|January 16, 2023
Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT StudyScott Kinlay, Melissa M Young, Rebecca Sherrod, et al.
BMC Medical Research Methodology|February 19, 2013
Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trialsWilliam M Reichmann, Michael P LaValley, David R Gagnon, et al.
Ophthalmology|March 17, 2004
Risk factors for central serous chorioretinopathy: a case-control studyRobert Haimovici, Sean Koh, David R Gagnon, et al.
European Heart Journal Open|January 21, 2026
Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary interventionRamael Ohiomoba, Edwin Mandieka, Melissa M Young, et al.
Archives of Internal Medicine|November 24, 2004
Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patientsJohn A Hermos, Melissa M Young, David R Gagnon, et al.
Statistics in Medicine|October 1, 2003
The analysis of survival data with a non-susceptible fraction and dual censoring mechanismsDavid R Gagnon, Mark E Glickman, Richard H Myers, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Lifetime Data Analysis|August 17, 2002
Modeling the effects of genetic factors on late-onset diseases in cohort studiesMark E Glickman, David R Gagnon
JAMA|November 10, 2020
New Statin Use and Mortality in Older Veterans-ReplyAriela R Orkaby, David R Gagnon, Luc Djousse
American Journal of Preventive Cardiology|September 9, 2024
Smoking and 10-year risk of cardiovascular and non-cardiovascular events after contemporary coronary stentingScott Kinlay, Melissa M Young, David R Gagnon
Journal of the American Geriatrics Society|March 26, 2021
Trends in 30-day mortality from COVID-19 among older adults in the Veterans Affairs systemBenjamin Seligman, Brian Charest, David R Gagnon, et al.
Journal of the American Heart Association|January 16, 2023
Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT StudyScott Kinlay, Melissa M Young, Rebecca Sherrod, et al.
BMC Medical Research Methodology|February 19, 2013
Impact of misspecifying the distribution of a prognostic factor on power and sample size for testing treatment interactions in clinical trialsWilliam M Reichmann, Michael P LaValley, David R Gagnon, et al.
Ophthalmology|March 17, 2004
Risk factors for central serous chorioretinopathy: a case-control studyRobert Haimovici, Sean Koh, David R Gagnon, et al.
European Heart Journal Open|January 21, 2026
Relationship of cancer and dual antiplatelet duration to long-term risk of ischaemic and bleeding outcomes after percutaneous coronary interventionRamael Ohiomoba, Edwin Mandieka, Melissa M Young, et al.
Archives of Internal Medicine|November 24, 2004
Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patientsJohn A Hermos, Melissa M Young, David R Gagnon, et al.
Statistics in Medicine|October 1, 2003
The analysis of survival data with a non-susceptible fraction and dual censoring mechanismsDavid R Gagnon, Mark E Glickman, Richard H Myers, et al.
Pageof 14